Loading asset research
XTL Biopharmaceuticals Ltd. American Depositary Shares
XTLBNasdaq · USD · StocksQuote as of · Exchange session not verified$2.56
+1.59%
Today
XTLB
Loading 1D prices…
Market cap
$6.3M
Volume
1.6K
52w high
$10.2852w low
$2.01Company profile
XTL Biopharmaceuticals Ltd. American Depositary Shares
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Herzliya, NY, United States
Employees
4
CIK
1023549
Session & valuation
Open$2.48
Previous close$2.52
Day high$2.56
Day low$2.47
30-day avg. volume9.3K
Outstanding shares946.2M
Diluted EPS-$0.80
Latest annual period
P/E (trailing)-3.20
P/E (forward)—
Price / book—
Beta0.45
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ENVBEnveric Biosciences Inc. Common Stock | $6.4M | $0.00 | — | -$36.24 | -1.37% | Unrated |
| ACXPAcurx Pharmaceuticals Inc. Common Stock | $6M | $0.00 | — | -$5.32 | 0.00% | Buy |
| KAPAKairos Pharma Ltd. Common Stock | $6M | $0.00 | — | -$0.30 | +4.64% | Buy |
| DRMADermata Therapeutics Inc. Common Stock | $5.9M | $0.00 | — | -$8.16 | -0.83% | Buy |
| PCSAProcessa Pharmaceuticals Inc. Common Stock | $5.8M | $0.00 | — | -$10.36 | +12.43% | Buy |